India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
Harbour BioMed brings advanced antibody discovery platforms to the table
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
This development marks a substantial improvement in the company's financial position and reflects strengthened promoter confidence
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Subscribe To Our Newsletter & Stay Updated
